Vascular Biogenics Ltd is a clinical-stage bio-pharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.
Stock Price Prediction
Update at 5:00pm EST
1.242 - 1.251
1.251 - 1.257
1.138 - 1.15
1.15 - 1.158
1.154 - 1.17
1.17 - 1.181
as of: 2019-11-19 12:32:12 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.VBLT has closed above bottom band by 11.2%. Bollinger Bands are 13.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
2019-11-15 -$0.14 Earnings Per Share Expected for Vascular Biogenics Ltd (NASDAQ:VBLT) This Quarter Equities analysts expect that Vascular Biogenics Ltd (NASDAQ:VBLT) will report ($0.14) earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have issued estimates for Vascular Biogenics’ earnings. Vascular Biogenics posted earnings of ($0.10) per share during the same quarter last year, which would indicate a negative year over year growth rate of […]
2019-08-06 Vascular Biogenics (VBLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Vascular Biogenics (VBLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.